{
    "2019-09-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Here's Why Glaxo (GSK) Steadily Stays Ahead of Its Industry",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "GSK",
                        "steadily",
                        "ahead",
                        "industry"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "China expands drug bulk-buy programme, puts pressure on pharma firms",
                "features": {
                    "keywords": [
                        "China",
                        "expands",
                        "drug",
                        "bulk-buy",
                        "programme",
                        "pressure",
                        "pharma"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}